Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy
NCT06268418
·
clinicaltrials.gov ↗
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Radionucleide Therapy
Interventions
OTHER:
Artificial intelligence
Sponsor
Central Hospital, Nancy, France